Cargando…
Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches
BACKGROUND: Marfan syndrome (MFS) is a heritable thoracic aortic disease with pervasive cardiovascular effects, including commonly, a dilated aortic root. Traditionally, the root is replaced using a mechanical composite valve graft (CVG); however, this valve-replacing (VR) approach necessitates a li...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405346/ https://www.ncbi.nlm.nih.gov/pubmed/37554715 http://dx.doi.org/10.21037/acs-2023-avs2-0085 |
_version_ | 1785085507014754304 |
---|---|
author | Coselli, Joseph S. Volguina, Irina V. Nguyen, Lynna Green, Susan Y. LeMaire, Scott A. Moon, Marc R. |
author_facet | Coselli, Joseph S. Volguina, Irina V. Nguyen, Lynna Green, Susan Y. LeMaire, Scott A. Moon, Marc R. |
author_sort | Coselli, Joseph S. |
collection | PubMed |
description | BACKGROUND: Marfan syndrome (MFS) is a heritable thoracic aortic disease with pervasive cardiovascular effects, including commonly, a dilated aortic root. Traditionally, the root is replaced using a mechanical composite valve graft (CVG); however, this valve-replacing (VR) approach necessitates a lifelong regimen of anticoagulation with a potential for late bleeding complications. In time, valve-sparing (VS) approaches were developed. Today, several options for aortic root replacement (ARR) exist; each has advantages and disadvantages that helps inform choice. The Aortic Valve Operative Outcomes in Marfan Patients (AVOMP) is a multi-center international registry to analyze clinical outcomes of ARR in MFS patients using either VR or VS techniques to better elucidate choice. We summarize outcomes of AVOMP and present our own experience. METHODS: We performed 223 consecutive elective ARR [1991–2023] in patients with MFS; 15 such repairs were included in AVOMP. Repairs included 113 (51%) using a mechanical CVG, 62 (28%) using a VS approach, and 48 (22%) using a bioprosthetic root. Many patients underwent aortic arch repair (30% to 54% by type). RESULTS: The median patient age was 38 [29–52] years. In comparing VS and VR groups, patients were similar in age and rates of major comorbidities and symptoms. Patients with VR repair had a more complex aortic history. The rate of redo sternotomy was 24% (n=54). Operative death was uncommon [4% overall (10/223); ranging from 2% to 8% by type], and stroke was rare [1/223 (<1%)]. Late survival and reoperation differed by operative approach; survival was improved in patients who underwent VS repair. CONCLUSIONS: We found that repair in patients with MFS undergoing ARR resulted in low operative risk. Our late results were similar to those of AVOMP in that patients undergoing VS repair tended to experience greater rates of valvular-structural deterioration, although this did not appear to impact survival. |
format | Online Article Text |
id | pubmed-10405346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-104053462023-08-08 Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches Coselli, Joseph S. Volguina, Irina V. Nguyen, Lynna Green, Susan Y. LeMaire, Scott A. Moon, Marc R. Ann Cardiothorac Surg Featured Articles BACKGROUND: Marfan syndrome (MFS) is a heritable thoracic aortic disease with pervasive cardiovascular effects, including commonly, a dilated aortic root. Traditionally, the root is replaced using a mechanical composite valve graft (CVG); however, this valve-replacing (VR) approach necessitates a lifelong regimen of anticoagulation with a potential for late bleeding complications. In time, valve-sparing (VS) approaches were developed. Today, several options for aortic root replacement (ARR) exist; each has advantages and disadvantages that helps inform choice. The Aortic Valve Operative Outcomes in Marfan Patients (AVOMP) is a multi-center international registry to analyze clinical outcomes of ARR in MFS patients using either VR or VS techniques to better elucidate choice. We summarize outcomes of AVOMP and present our own experience. METHODS: We performed 223 consecutive elective ARR [1991–2023] in patients with MFS; 15 such repairs were included in AVOMP. Repairs included 113 (51%) using a mechanical CVG, 62 (28%) using a VS approach, and 48 (22%) using a bioprosthetic root. Many patients underwent aortic arch repair (30% to 54% by type). RESULTS: The median patient age was 38 [29–52] years. In comparing VS and VR groups, patients were similar in age and rates of major comorbidities and symptoms. Patients with VR repair had a more complex aortic history. The rate of redo sternotomy was 24% (n=54). Operative death was uncommon [4% overall (10/223); ranging from 2% to 8% by type], and stroke was rare [1/223 (<1%)]. Late survival and reoperation differed by operative approach; survival was improved in patients who underwent VS repair. CONCLUSIONS: We found that repair in patients with MFS undergoing ARR resulted in low operative risk. Our late results were similar to those of AVOMP in that patients undergoing VS repair tended to experience greater rates of valvular-structural deterioration, although this did not appear to impact survival. AME Publishing Company 2023-07-14 2023-07-31 /pmc/articles/PMC10405346/ /pubmed/37554715 http://dx.doi.org/10.21037/acs-2023-avs2-0085 Text en 2023 Annals of Cardiothoracic Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Featured Articles Coselli, Joseph S. Volguina, Irina V. Nguyen, Lynna Green, Susan Y. LeMaire, Scott A. Moon, Marc R. Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title | Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title_full | Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title_fullStr | Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title_full_unstemmed | Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title_short | Outcomes of aortic root replacement in patients with Marfan syndrome: the role of valve-sparing and valve-replacing approaches |
title_sort | outcomes of aortic root replacement in patients with marfan syndrome: the role of valve-sparing and valve-replacing approaches |
topic | Featured Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405346/ https://www.ncbi.nlm.nih.gov/pubmed/37554715 http://dx.doi.org/10.21037/acs-2023-avs2-0085 |
work_keys_str_mv | AT cosellijosephs outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches AT volguinairinav outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches AT nguyenlynna outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches AT greensusany outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches AT lemairescotta outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches AT moonmarcr outcomesofaorticrootreplacementinpatientswithmarfansyndrometheroleofvalvesparingandvalvereplacingapproaches |